Embecta Corp. (EMBC)
6.27
-0.18
(-2.79%)
USD |
NASDAQ |
Oct 16, 16:00
6.285
+0.02
(+0.24%)
After-Hours: 20:00
Embecta Net Income (TTM) : 87.50M for June 30, 2026
Net Income (TTM) Chart
Historical Net Income (TTM) Data
| Date | Value |
|---|---|
| June 30, 2026 | 87.50M |
| March 31, 2026 | 111.90M |
| December 31, 2025 | 139.50M |
| September 30, 2025 | 95.40M |
| June 30, 2025 | 83.60M |
| March 31, 2025 | 52.80M |
| December 31, 2024 | 58.20M |
| September 30, 2024 | 78.30M |
| June 30, 2024 | 69.70M |
| March 31, 2024 | 70.20M |
| Date | Value |
|---|---|
| December 31, 2023 | 55.30M |
| September 30, 2023 | 70.40M |
| June 30, 2023 | 47.20M |
| March 31, 2023 | 94.40M |
| December 31, 2022 | 160.00M |
| September 30, 2022 | 223.60M |
| June 30, 2022 | 337.90M |
| March 31, 2022 | 380.20M |
| December 31, 2021 | 408.50M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (TTM) Benchmarks
| Artivion, Inc. | -3.159M |
| Abbott Laboratories | 5.405B |
| AngioDynamics, Inc. | -32.94M |
| Alphatec Holdings, Inc. | -109.99M |
| AtriCure, Inc. | 10.55M |